text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 366789-02-8 | Product Number: R0269

Rivaroxaban


Purity: >98.0%(T)(HPLC)
Synonyms:
  • (S)-5-Chloro-N-[[2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl]methyl]thiophene-2-carboxamide
Product Documents:
1G
¥150.00
2   Contact Us 3  
5G
¥520.00
4   Contact Us 16  

* For order or inquiry, please contact Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.


Product Number R0269
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__1__9H__1__8ClN__3O__5S = 435.88 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Air Sensitive,Heat Sensitive
Packaging and Container 1G-Glass Bottle with Plastic Insert (View image)
CAS RN 366789-02-8
Reaxys Registry Number 10206739
MDL Number

MFCD11974010

Specifications
Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Volumetric Analysis) min. 98.0 %
Melting point 230.0 to 234.0 °C
Specific rotation -40.0 to -44.0 deg(C=1, DMSO)
NMR confirm to structure
Properties (reference)
Melting Point 232 °C
Solubility in water Insoluble
Solubility (soluble in) Dimethylformamide
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H361 : Suspected of damaging fertility or the unborn child.
H371 : May cause damage to organs.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray.
P270 : Do not eat, drink or smoke when using this product.
P202 : Do not handle until all safety precautions have been read and understood.
P201 : Obtain special instructions before use.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection.
P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor.
P405 : Store locked up.
Related Laws:
Transport Information:
Customs Control Conditions (Q)
Application
Rivaroxaban: A Selective Inhibitor of the Serine Protease, Activated Anticoagulant Factor X (FXa)

Rivaroxaban (BAY 59-7939) is a selective inhibitor of the serine protease, activated anticoagulant factor X (FXa) that catalyzes the conversion of prothrombin to thrombin. Rivaroxaban works by selectively and reversibly blocking the activity of clotting FXa, thereby preventing the formation of blood clots. Thus, inhibition of FXa may block this burst of thrombin generation, thereby reducing thrombin-mediated activation of coagulation and platelets. In another words, rivaroxaban does not directly affect platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. (The product is for research purpose only.)

References


Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.